GMP VA UNING O‘ZBEKISTON FARMATSEVTIKA TARMOQLARIDA RIVOJLANISH ISTIQBOLLARI
Abstract
GMP muvofiqligini olish va qo‘llab-quvvatlash uchun har bir menejer va nazoratchi tez-tez, mazmunli GMP eslatmalarini berishi, barcha xodimlari o‘qitishi, rivojlanishi va rasmiy davom etadigan o‘quv dasturlarida to‘liq ishtirok etishi kerak. Yuqori rahbariyat jamoatchilikka e’lon qilishi va o‘zlarining xatti-harakatlari bilan GMPlarga ergashish ularning kompaniyalari faoliyatining yagona usuli ekanligini aniq ko‘rsatishi kerak. Yuqori rahbariyat jamoatchilikka e’lon qilishi va o‘zlarining xatti harakatlari bilan GMPlarga ergashish ularning kompaniyalari faoliyatining yagona usuli ekanligi aniq ko‘rsatishi kerak.
References
S. Ward, “Summary of The Jungle by Upton Sinclair,” SparkNotes
Online Study Guide (TheSpark.com Inc., Cambridge, MA, 1999),
www.sparknotes.com/guides/jungle
Requirements of Laws and Regulations Enforced by the U.S. Food and
Drug Administration (FDA, Rockville, MD, revised 1997), www.fda.gov/opacom/morechoices/smallbusiness/blubook.htm
Office of Women’s Health, FDA Milestones in Women’s Health: Looking Back as We Move into the New Millennium (FDA, Rockville,MD,2000), www.fda.gov/womens/milesbro.html.
FDA History: FDA Commissioners and Their Predecessors (FDA,
Rockville, MD, rev. 6 April 2000), www.fda.gov/opacom/morechoices/comm1.html.
R. Roberts, Safety Assessment in Pediatrics (Center for Drug Evaluation and Research, FDA, 8 July 1999), www.fda.gov/cder/present/dia-699/sa-dia99/index.htm.
Center for Drug Evaluation and Research, Time Line: Chronology of
Drug Regulation in the United States (FDA, Rockville, MD), www.fda.gov/cder/about/history/time1.htm
“Milestones in US Food and Drug Law History,” in FDA Backgrounder:
Current and Useful Information from the Food and Drug Administration (FDA, Rockville, MD, August 1995), www.fda.gov/opacom/backgrounders/miles.html.
“Jonas Salk, MD – Biography” (American Academy of Achievement,2000), www.achievement.org/autodoc/halls/sci
I.B. Stehlin, “Assessing Risks with Polio Vaccines,” FDA Consumer 29(10)(December1995), www.fda.gov/fdac/features/095_vacc.html.
Code of Federal Regulations, Title 21, Food and Drugs, “Current Good
Manufacturing Practice in Manufacturing, Processing, Packing, or
Holding of Drugs,” Part 210–211 (US Printing Office, Washington,
DC, revised April 2000).
Code of Federal Regulations, Title 21, Food and Drugs, “Medical Devices: Current Good Manufacturing Practices (CGMP) Final Rule,”
Part 820 (US Printing Office, Washington, DC, revised April 1999)
T. Nordenberg, “FDA and Medical Devices: After 20 Years, a Look Back, a Look Ahead,” FDA Consumer 30 (10) (December 1996), www.fda.gov/fdac/features/096_mdev.html
National Center for Drugs and Biologics, Guide to Inspection of Computerized Systems in Drug Processing (FDA, Rockville, MD, February1983), www.fda.gov/ora/inspect_ref/igs/csd.html.
Center for Drug Evaluation and Research, Guideline on General Principles of Process Validation (FDA, Rockville, MD, May 1987), www.fda.gov/cder/guidance/pv.htm.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
